Description
CARTS
冠状动脉血运重建治疗峰会
本次大会将邀请国内著名心脏病学专家莅临讲学,旨在加强全国心脏病学同仁间的学术交流、探讨心脏病学领域的热点、难点问题，学习国内外心脏病学研究的新进展、新成就，既注重心脏病学领域的前沿讯息，又注重基层心脏病学的发展,继续为心脏病学同仁提供更广泛交流的平台。在此诚邀您的参与，共襄学术盛宴。
本APP是冠状动脉血运重建治疗峰会学术会议官方指定APP，提供会议指南查询，日程查询，和查询等功能。
冠状动脉血运重建治疗峰会
本次大会将邀请国内著名心脏病学专家莅临讲学,旨在加强全国心脏病学同仁间的学术交流、探讨心脏病学领域的热点、难点问题，学习国内外心脏病学研究的新进展、新成就，既注重心脏病学领域的前沿讯息，又注重基层心脏病学的发展,继续为心脏病学同仁提供更广泛交流的平台。在此诚邀您的参与，共襄学术盛宴。
本APP是冠状动脉血运重建治疗峰会学术会议官方指定APP，提供会议指南查询，日程查询，和查询等功能。
Screenshots
CARTS FAQ
-
Is CARTS free?
Yes, CARTS is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is CARTS legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does CARTS cost?
CARTS is free.
-
What is CARTS revenue?
To get estimated revenue of CARTS app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Denmark yet.
Ratings History
CARTS Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
CARTS Installs
Last 30 days
CARTS Revenue
Last 30 daysCARTS Revenue and Downloads
Gain valuable insights into CARTS performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Beijing Yilihong Technology Co
- Languages
- English, Chinese
- Recent release
- 2.0.3 (2 years ago )
- Released on
- Oct 29, 2021 (3 years ago )
- Also available in
- China, Peru, Indonesia, India, Italy, Japan, South Korea, Kuwait, Mexico, Nigeria, Norway, New Zealand, Hungary, Pakistan, Poland, Romania, Thailand, Türkiye, Taiwan, United States, Vietnam, South Africa, Denmark, Austria, Australia, Azerbaijan, Belarus, Canada, Switzerland, Chile, Colombia, Germany, United Arab Emirates, Dominican Republic, Algeria, Ecuador, Egypt, Spain, France, United Kingdom, Greece, Hong Kong SAR China
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.